---
title: "Xtandi (enzalutamide), all indications: Specific populations questions"
description: "Specific populations questions on Xtandi (enzalutamide) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Pregnancy and breastfeeding and Pediatric use. Questions: Does Xtandi need a dose adjustment for kidney impairment? Does Xtandi need a dose adjustment for liver impairment? Do Xtandi safety and effectiveness differ in patients 65 and older? Can Xtandi cause harm during pregnancy? 4 further questions follow. 8 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/xtandi/specific-populations"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xtandi (enzalutamide), all indications: Specific populations questions

Manufacturer: Astellas Pharma US, Inc.; Pfizer Inc.  
Prescribing information: [Xtandi](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf)  
Indication pages: [Castration-resistant prostate cancer](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer)

## Specific populations

<a id="xtandi-kidney-impairment"></a>

### Does Xtandi need a dose adjustment for kidney impairment?

> “No dosage modification is recommended for patients with mild to moderate renal impairment (creatinine clearance [CLcr] 
> ≥ 30 mL/min). XTANDI has not been studied in patients with severe renal impairment (CLcr < 30 mL/min) or end-stage 
> renal disease [see Clinical Pharmacology (12.3)].”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

<a id="xtandi-liver-impairment"></a>

### Does Xtandi need a dose adjustment for liver impairment?

> “No dosage modification is recommended for patients with mild, moderate, or severe hepatic impairment [see Clinical 
> Pharmacology (12.3)].”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

<a id="xtandi-older-adults"></a>

### Do Xtandi safety and effectiveness differ in patients 65 and older?

> “Of 5112 patients who received XTANDI in eight randomized, controlled clinical trials, 78% were 65 and over, while 33% 
> were 75 and over. No overall differences in safety or effectiveness were observed between these patients and younger 
> patients. Other reported clinical experience has not identified differences in responses between the elderly and younger 
> patients, but greater sensitivity of some older individuals cannot be ruled out.”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

Note: The Prescribing Information pools its eight randomized, controlled trials across patients with CRPC (N = 3651), mCSPC (N = 754), and nmCSPC with high-risk BCR (N = 707).

<a id="xtandi-male-fertility"></a>

### Can Xtandi affect male fertility?

> “Based on animal studies, XTANDI may impair fertility in males of reproductive potential [see Nonclinical Toxicology 
> (13.1)].”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

## Pregnancy and breastfeeding

<a id="xtandi-pregnancy"></a>

### Can Xtandi cause harm during pregnancy?

> “The safety and efficacy of XTANDI have not been established in females. Based on animal reproductive studies and 
> mechanism of action, XTANDI can cause fetal harm and loss of pregnancy. There are no human data on the use of 
> XTANDI in pregnant females.”

Source: [XTANDI: Prescribing information, page 14, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=14)

<a id="xtandi-contraception"></a>

### Do men taking Xtandi need to use contraception?

> “Based on findings in animal reproduction studies, advise male patients with female partners of reproductive potential to 
> use effective contraception during treatment and for 3 months after the last dose of XTANDI [see Use in Specific 
> Populations (8.1)].”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

> “Advise male patients with female partners of reproductive potential to use effective contraception during 
> treatment and for 3 months after the last dose of XTANDI. Advise male patients to use a condom if having sex 
> with a pregnant woman”

Source: [XTANDI: Prescribing information, page 33, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=33)

<a id="xtandi-breastfeeding"></a>

### Does Xtandi pass into breast milk?

> “The safety and efficacy of XTANDI have not been established in females. There is no information available on the 
> presence of XTANDI in human milk, the effects of the drug on the breastfed infant, or the effects of the drug on milk 
> production. Enzalutamide and/or its metabolites were present in milk of lactating rats (see Data).”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

## Pediatric use

<a id="xtandi-children"></a>

### Is Xtandi safe and effective in children?

> “Safety and effectiveness of XTANDI in pediatric patients have not been established.”

Source: [XTANDI: Prescribing information, page 15, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=15)

## Related pages
- [Medical information: Xtandi (enzalutamide): All indications](https://www.evicenter.com/medical-information/xtandi)
- [Indication](https://www.evicenter.com/medical-information/xtandi/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/xtandi/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/xtandi/safety)
- [Drug interactions](https://www.evicenter.com/medical-information/xtandi/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/xtandi/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/xtandi/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/xtandi/access-and-coverage)
